Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles

被引:565
作者
Ahmed, F
Discher, DE
机构
[1] Univ Penn, Dept Chem Biomol Engn, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
PEG-PLA; PEG-PCL; hydrolytic degradation; bilayer membranes; micelles;
D O I
10.1016/j.jconrel.2003.12.021
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Controlled release polymer vesicles are prepared using hydrolysable diblock copolymers of polyethyleneglycol-poly-L-lactic acid (PEG-PLA) or polyethyleneglycol-polycaprolactone (PEG-PCL). Encapsulation studies with a common anticancer agent, doxorubicin, show loading comparable to liposomes. Rates of encapsulant release from the hydrolysable vesicles are accelerated with an increased proportion of PEG but are delayed with a more hydrophobic chain chemistry (i.e. PCL). Rates of release also rise linearly with the molar ratio of degradable copolymer blended into membranes of a non-degradable, PEG-based block copolymer (PEG-polybutadiene (PBD)). With all compositions, in both 100 nm and giant vesicles, the average release time (from hours to days) reflects a highly quantized process in which any given vesicle is either intact and retains its encapsulant, or is porated and slowly disintegrates. Poration occurs as the hydrophobic PLA or PCL block is hydrolytically scissioned, progressively generating an increasing number of pore-preferring copolymers in the membrane. Kinetics of this evolving detergent mechanism overlay the phase behavior of amphiphiles with transitions from membranes to micelles allowing controlled release. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 53
页数:17
相关论文
共 89 条
[1]
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity [J].
Adlakha-Hutcheon, G ;
Bally, MB ;
Shew, CR ;
Madden, TD .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :775-779
[2]
Block copolymer assemblies with cross-link stabilization: From single-component monolayers to bilayer blends with PEO-PLA [J].
Ahmed, F ;
Hategan, A ;
Discher, DE ;
Discher, BM .
LANGMUIR, 2003, 19 (16) :6505-6511
[3]
Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone [J].
Allen, C ;
Han, JN ;
Yu, YS ;
Maysinger, D ;
Eisenberg, A .
JOURNAL OF CONTROLLED RELEASE, 2000, 63 (03) :275-286
[4]
Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[5]
Araki H, 1999, ARTIF ORGANS, V23, P161
[6]
Arcamone F., 1981, DOXORUBICIN ANTICANC
[7]
PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[8]
POLYMER-POLYMER PHASE-BEHAVIOR [J].
BATES, FS .
SCIENCE, 1991, 251 (4996) :898-905
[9]
Block copolymers - Designer soft materials [J].
Bates, FS ;
Fredrickson, GH .
PHYSICS TODAY, 1999, 52 (02) :32-38
[10]
In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities [J].
Belbella, A ;
Vauthier, C ;
Fessi, H ;
Devissaguet, JP ;
Puisieux, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :95-102